FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to an agent for treating skin purulent infections, containing microcrystalline fusidic acid, an emulsion base (butylhydroxyanisol, emulsifier No.1, distilled glycerol, Vaseline oil, potassium sorbate, tween 80, medical white Vaseline, purified water) and additionally zinc oxide. The invention also concerns methods for preparing the specified agent.
EFFECT: developing an integrated preparation for treating purulent skin infections on the emulsion base that enables higher therapeutic effectiveness and reduced length of treatment.
3 cl, 2 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR SUPERFICIAL MYCOSES TREATMENT | 2007 |
|
RU2337689C1 |
PHARMACEUTICAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF COLD-RELATED DISEASES AND HERPES SIMPLEX, AND METHOD FOR MAKING THEREOF | 2008 |
|
RU2373950C1 |
LOCAL COMPOSITION CONTAINING AMBROXOL | 2005 |
|
RU2381794C2 |
PHARMACEUTICAL COMPOSITION OF ANTIVIRAL AND ANTI-INFLAMMATORY ACTION | 2015 |
|
RU2596499C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING ATOPIC DERMATITIS AND METHOD FOR PREPARING IT | 2013 |
|
RU2538680C2 |
SKIN CARE COMPOSITION, CONTAINING FATTY ACIDS FROM TALL OIL AND VEGETABLE OILS, FOR DRY OR SCALING SKIN, AND TREATMENT FOR PSORIASIS, DERMATITIS AND ECZEMA | 2004 |
|
RU2339362C2 |
COMBINED PREPARATION FOR TREATING SKIN DISEASES | 2002 |
|
RU2223097C1 |
OINTMENT WITH BEE MOTH LARVAE EXTRACT AND PROPOLIS EXTRACT FOR PREVENTION AND INTEGRATED TREATMENT OF VIRAL INFECTION | 2011 |
|
RU2477141C2 |
FACE SKIN CREAM | 1992 |
|
RU2038071C1 |
OINTMENT COMPOSITION FOR LOCAL APPLICATION HAVING ANTIACNEIC PHARMACOLOGICAL ACTIVITY | 2012 |
|
RU2500395C1 |
Authors
Dates
2013-01-20—Published
2011-08-05—Filed